Add Company
Join Now

OrsoBio Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • OrsoBio's estimated annual revenue is currently $1M per year.(i)
  • OrsoBio's estimated revenue per employee is $53,026

Employee Data

  • OrsoBio has 19 Employees.(i)
  • OrsoBio grew their employee count by 46% last year.

OrsoBio's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Medical Officer and Head DevelopmentReveal Email/Phone
3
Chief Medical Officer and Head DevelopmentReveal Email/Phone
4
VP, Clinical Development & OperationsReveal Email/Phone
5
VP Product Development and Program ManagementReveal Email/Phone
6
Director, Regulatory AffairsReveal Email/Phone
7
ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M50%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M4-50%N/AN/A
#6
$0.7M80%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1731%N/AN/A
Add Company

What Is OrsoBio?

OrsoBio, Inc. is a privately held, clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders, including type 2 diabetes, severe dyslipidemias, lipodystrophies, and nonalcoholic steatohepatitis. OrsoBio currently has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism.

keywords:N/A

N/A

Total Funding

19

Number of Employees

$1M

Revenue (est)

46%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.2M1912%N/A
#2
$4.4M19-5%N/A
#3
$2.3M19-14%N/A
#4
$2.8M19-30%N/A
#5
$3.5M19N/AN/A